Fructose Supplementation in Carriers for Hereditary Fructose Intolerance
Metabolic Effects of Short-term Dietary Supplementation With Fructose in Carriers for Hereditary Fructose Intolerance
1 other identifier
interventional
12
1 country
1
Brief Summary
This study aimed to examine metabolic response to a short-term fructose enriched diet in carriers for hereditary fructose intolerance compared to controls. Effects of fructose coffees will be assessed in 7 healthy volunteers and 7 subjects with heterozygous mutation for ALDOB gene in a randomized, controlled, crossover trial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2018
CompletedFirst Submitted
Initial submission to the registry
May 7, 2018
CompletedFirst Posted
Study publicly available on registry
June 4, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2019
CompletedApril 22, 2019
April 1, 2019
7 months
May 7, 2018
April 19, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Metabolite concentration
The primary endpoint is the change of metabolite concentration after ingestion of a test meal (oral glucose and fructose load) under 2 conditions (enriched fructose diet vs poor fructose diet) according to a crossover design
Time Frame: -30 min before ingestion of a test meal to 120 min after ingestion of a test meal
Secondary Outcomes (20)
Plasma glucose concentration
Time Frame: -30 min before ingestion of a test meal to 120 min after ingestion of a test meal
Plasma insulin concentration
Time Frame: -30 min before ingestion of a test meal to 120 min after ingestion of a test meal
Plasma fructose concentration
Time Frame: -30 min before ingestion of a test meal to 120 min after ingestion of a test meal
Plasma uric acid concentration
Time Frame: -30 min before ingestion of a test meal to 120 min after ingestion of a test meal
Plasma lactate concentration
Time Frame: -30 min before ingestion of a test meal to 120 min after ingestion of a test meal
- +15 more secondary outcomes
Study Arms (2)
Experimental diet Fru rich diet
OTHEREnriched fructose diet from day 1 to day 7.
Experimental low Fru diet
OTHERLow fructose diet from day 1 to day 7.
Interventions
7 days (day 1 to day 7) with fructose enriched drinks 3x/d. Test meal at day 7 with fructose (0.7 g/body weight) and glucose (0.7 g/body weight)
7 days (day 1 to day 7) with low-fructose diet (\<10g/d). Test meal at day 7 with fructose (0.7 g/body weight) and glucose (0.7 g/body weight)
Eligibility Criteria
You may qualify if:
- Case subjects: Heterozygous carriers for ALDOB mutation confirmed by molecular analysis
- Control subjects: healthy individuals matched for weight and age to subjects
You may not qualify if:
- Fasting glucose \> 7.0 mmol/L
- Fasting triglycerides \> 4.0 mmol/L
- Chronic renal insufficiency (eGFR \< 50 ml/min)
- Drugs
- Women who are pregnant or breast feeding
- For women: lack of safe contraception
- Alcool consumption \> 30g/d
- Inability to discern
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Lausannelead
- University of Liegecollaborator
Study Sites (1)
Guillaume Debray
Liège, Belgium
Related Publications (1)
Debray FG, Seyssel K, Fadeur M, Tappy L, Paquot N, Tran C. Effect of a high fructose diet on metabolic parameters in carriers for hereditary fructose intolerance. Clin Nutr. 2021 Jun;40(6):4246-4254. doi: 10.1016/j.clnu.2021.01.026. Epub 2021 Jan 27.
PMID: 33551217DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
May 7, 2018
First Posted
June 4, 2018
Study Start
May 1, 2018
Primary Completion
December 1, 2018
Study Completion
April 1, 2019
Last Updated
April 22, 2019
Record last verified: 2019-04